Abstract
Alphavirus vectors have proven useful for various in vitro and in vivo applications. The rapid generation of high-titer recombinant alphavirus particles has resulted in overexpression of topologically different recombinant proteins in a broad range of mammalian host cells. The same replication-deficient alphavirus particles have been subjected to in vivo gene delivery studies. These features have made alphavirus vectors attractive for various approaches in drug discovery. Large-scale production of recombinant G protein-coupled receptors and ligand-gated ion channels has significantly facilitated drug screening procedures and purification of receptor protein for biostructural studies. Modified alphavirus vectors with lower cytotoxicity and a temperature-sensitive phenotype has allowed prolonged survival of host cells and inducible expression studies. Furthermore, vectors have been engineered for functional expression of cDNA libraries and the use of vector for anfisense and ribozyme applications. Preliminary studies in animal models have indicated that alphaviruses are potentially attracdve for gene therapy applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agapov, E.V., I. Frolov, B.D. Lindenbach, B.M. Pragai, S. Schlesinger, and CM. Rice. “Noncytopathogenic Sindbis RNA vectors for heterologous gene expression”. Proc. Natl. Acad. Sci. USA 95 (1998): 12989–12994.
Altman-Hamandzic, S., C. Groceclose, J.-X. Ma, D. Hamandzic, N. S. Vrindavanam, L.D. Middaugh, N.R Paratto, and F.R. Sallee. “Expression of ß-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system”. Gene Then 4 (1997): 815–822.
Asselin-Paturel, C., N. Lassau, J.-M. Guinebredere, J. Zhang, F Gay, F. Bex, S. Hallez, J. Leclere, P. Peronneau, F. Mami-Choauib, and S. Chouaib. “Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces tumor regerssion through inhibition of tumor blood vessel formadon monitored by Doppler ultrasynography”. Gene Then 6 (1999): 606–615.
Blasey, H.D., K. Lundstrom, S. Tate, and A.R. Bernard. “Recombinant protein production using the Semliki Forest virus expression system”. Cytotechnology 24 (1997): 65–72.
Boorsma, M., D. Koller, and M.R Bachmann. “New applications of alphavirus-based expression vectors”. Cytotechnology (2001): in press.
Boorsma, M., L. Nieba, D. Koller, M.F. Bachmann, J.E. Bailey, and W.A. Renner. “A temperature-regulated replicon-based DNA expression system”. Nat. Biotech. 18 (2000): 429–432.
Davis, N.L., L.W. Willis, J.F. Smith, and R.E. Johnston. “In vitro synthesis of infectious Venezuelan equine encephahtis virus RNA from a cDNA clone: analysis of a viable deletion mutant”. Virology 171 (1989): 189–204.
Ehrengruber, M.U., K. Lundstrom, C. Schweitzer, C. Heuss, S. Schlesinger, and B.H. Gähwiler. “Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures”. Proc. Natl. Acad Sci. USA 96 (1999): 7041–7046.
Ehrengruber, M.U., S. Hennou, H. Büeler, H.Y. Naim, N. Déglon, and K. Lundstrom. “Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest virus, adenovirus, adeno-associated virus, lentivirus, and measles virus”. Mol. Cell. Neurosci. 17 (2001): 855–871.
Hovius, R., A.-P. Tain, H. Blasey, A. Bernard, K. Lundstrom, and H. Vogel. “Characterization of a mouse serotonin 5-HT3 receptor purified from mammalian cells”. J. Neurochem. 70 (1998): 824–834.
Liljeström, P., and H. Garoff. “A new generation of animal cell expression vectors based on the Semliki Forest virus replicon”. Bio/Technology 9 (1991): 1356–1361.
Lundstrom, K. “Alphavirus vectors as tools in neurobiology and gene therapy”. J. Receptor & Signal Transd. Res. 19 (1999): 673–686.
Lundstrom, K. “Alphavirus vectors: applications for DNA vaccine and gene expression”. Intervirology 43 (2000): 247–257.
Lundstrom. K., A.B. Hawcock, A. Vargas, P. Ward, P. Thomas, and A. Naylor. “Effect of single point mutations of the human tachykinin NKl receptor on antagonist activity”. Eun J. Pharmacol. 337 (1997a): 73–81.
Lundstrom, K., F. Knoflach, F. Goepfert, H. Schaffhauser, J.R. Pink, Y. Borer, P Ziltener, and V. Mutel. “Functional expression of metabotropic glutamate receptors in primary neurons infected with Semliki Forest virus vectors”. J. Neurochem. 73Suppl. 1 (1998a): S86C.
Lundstrom, K., A. Michel, H.D. Blasey, A.R. Bernard, R. Hovius, H. Vogel, and A. Surprenant. “Expression of ligand-gated ion channels with the Semhki Forest virus expression system”. J Receptor & Sign. Transd. Res. 17 (1997b): 115–128.
Lundstrom, K., A. Mills, G. Buell, E. Allet, N. Adami, and R Liljeström. “High-level expression of the human neurokinin-1 receptor in mammalian cell lines using the Semliki Forest virus expression system”. Eur J. Biochem. 224 (1994): 917–921.
Lundstrom, K., J.G. Richards, J.R. Pink, and F. Jenck. “Efficient in vivo expression of a reporter gene in rat brain after injection of recombinant replication-deficient Semliki Forest virus”. Gene Then Mol. Biol. 3 (1999a): 15–23.
Lundstrom, K., D. Rotmann, D. Hermann, E.M. Schneider, and M.U. Ehrengruber. “Novel mutant Semliki Forest virus vectors: gene expression and locaUzation studies in neuronal cells”. Histochem. Cell Biol. 115 (2001): 83–91.
Lundstrom, K., C. Schweitzer, J.G. Richards, M.U. Ehrengruber, F. Jenck, and C. Miilhardt. “Semliki Forest virus vectors for in vitro and in vivo apphcations”. Gene Then Mol. Biol. 4 (1999b): 23–31.
Lundstrom, K., and M.P. Turpin. “Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system”. Biochem. Biophys. Res. Comm. 225 (1996): 1068–1072.
Lundstrom, K., M.P. Turpin, C. Large, G. Robertson, P. Thomas, and X.Q. Lewell. “Mapping of the dopamine D3 receptor binding site by pharmacological characterizadon of mutants expressed in CHO cells with the Semliki Forest virus system”. J. Receptor & Sign. Transd. Res. 18 (1998b): 133–150.
Murphy, A.-M., M.M. Morris-Downes, B.J. Sheahan, and G.J. Atkins. “Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles”. Gene Then 7 (2000): 1477–1482.
Olkkonen, V.M., P. Liljeström, H. Garoff, K. Simons, and C. Dotti. “Expression of heterologous proteins in cultured rat hippocampal neurons using Semliki Forest virus vector”. J. Neurosci. Res. 35 (1993): 445–451.
Perri, S., D.A. Driver, J.R Gardner, S. Sherrill, B.A. Belli, T.W. Dubensky Jr., and J.M. Polo. “Replicon vectors derived from Sindbis virus and Semliki Forest virus that estabhshed persistent replication in host cells”. J. Virol. 74 (2000): 9802–9807.
Scheer, A., K. Björklöf, S. Cotecchia, and K. Lundstrom. “Expression of the αlB-adrenergic receptor and G protein subunits in mammalian cells using the Semliki Forest virus expression system”. J. Receptor & Sign. Transd. Res. 19 (1999): 369–378.
Schlaeger, E.-J., and K. Lundstrom. “Effect of temperatureon recombinant protein expression in Semliki Forest virus infected mammalian cell lines growing in serum-free suspension cultures”. Cytotechnology 28 (1998): 205–211.
Smith, S.M., F. Maldarelli, and K.-T. Jeang. “Effiecient expression by an alphavirus replicon of a functional ribozyme targeted to human immunodeficiency virus type 1”. J. Virol. 71 (1997): 9713–9721.
Sjöberg, E.M., Suomalainen, M., and Garoff, H. “A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene”. Bio/Technology 12 (1994): 1127–1131.
Xiong, C, R. Levis, P. Shen, S. Schlesinger, CM. Rice, and H.V Huang. “Sindbis virus: an efficient broad host range vector for gene expression in animal cells”. Science 243 (1989): 1188–1191.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Lundstrom, K. (2001). Application of Alphavirus Vectors in Drug Discovery. In: Lindner-Olsson, E., Chatzissavidou, N., Lüllau, E. (eds) Animal Cell Technology: From Target to Market. ESACT Proceedings, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0369-8_11
Download citation
DOI: https://doi.org/10.1007/978-94-010-0369-8_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-3897-3
Online ISBN: 978-94-010-0369-8
eBook Packages: Springer Book Archive